Canadian pilot study uses gene therapy to successfully treat patients with Fabry disease
Results of a world-first Canadian pilot study on patients treated with gene therapy for Fabry disease show that the treatment is working and safe.
The Canadian research team was the first to use gene therapy in 2017 to treat patients with Fabry disease, a rare, chronic illness that can damage major organs and shorten lives. They report their findings today in the journal
Nature Communications. Being one of the first people in the world to receive this treatment, and seeing how much better I felt afterward, it definitely gives me hope that this can help many other Fabry patients and potentially those with other single gene mutation disorders, says Ryan Deveau, one of the participating patients in Dartmouth, Nova Scotia. Now that I don t have to get the replacement therapy every two weeks, I have more time to spend with my family.
A Canadian success story: world-first to treat Fabry disease with gene therapy newswise.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswise.com Daily Mail and Mail on Sunday newspapers.
Can We Hang Out With Grandparents Once They re Vaccinated?
We’re all counting down the days until we can visit family worry-free, but experts warn it may not be when Grandma and Grandpa get their shots. Erin Pepler, Today s Parent Updated
February 23, 2021
(Photo: Photo: iStock/kate sept2004)
My sleeve is already rolled up in excited anticipation of getting my COVID vaccine, but the reality is, it won’t be happening for me anytime soon. And that’s OK I’m not a frontline worker or a high-risk individual, so I’m happy to wait my turn while people like my parents and in-laws get their vaccines earlier on.
Toronto Pearson International Airport (CNW Group/Greater Toronto Airports Authority)
TORONTO The Greater Toronto Airports Authority (GTAA) announced a new COVID-19 PCR and antigen testing research program at Toronto Pearson. The program, which starts on March 1, is supported in part by funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). It is designed to explore the efficacy of antigen testing, compared with the rapid polymerase chain reaction (PCR) test, in a high-throughput, commercial environment, as well as the operationalization of rapid PCR testing in an airport environment.
“The GTAA continues to demonstrate its commitment and leadership in the exploration of the science of COVID-19 testing. Science is at the heart of our Healthy Airport commitment and we are pleased to receive this support from NRC IRAP on this additional testing program, as we pursue further innovation here at Toronto Pearson,” said Deborah Flint, P
Greater Toronto Airports Authority to lead rapid COVID-19 point-of-need testing research newswire.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newswire.ca Daily Mail and Mail on Sunday newspapers.